# XTL Biopharmaceuticals Ltd: Form 6-K, filed Jun 23, 2026

- Company: [XTL Biopharmaceuticals Ltd](/companies/xtlb.md) (CIK 1023549)
- Form: 6-K
- Filed: 2026-06-23
- Accepted by EDGAR: Jun 22, 2026, 23:23 ET
- Period: 2026-06-22
- Accession: 0001213900-26-070771
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1023549/000121390026070771/ea0295469-6k_xtlbio.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1023549/000121390026070771/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1023549/000121390026070771/ea0295469-6k_xtlbio.htm

Filed Jun 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-070771. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.